BMS-214662 Uses, Dosage, Side Effects and more
BMS-214662 has been used in trials studying the treatment of Childhood Myelodysplastic Syndromes, Refractory Anemia With Excess Blasts, Recurrent Adult Acute Myeloid Leukemia, Relapsing Chronic Myelogenous Leukemia, and Adult Acute Promyelocytic Leukemia (M3), among others.
| Trade Name | BMS-214662 |
| Generic | BMS-214662 |
| Type | |
| Formula | C25H23N5O2S2 |
| Weight | Average: 489.612 Monoisotopic: 489.129316385 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
